NEWS: CGEN, CBRX, AMRN, RGDX, ADHD CGEN finance.yahoo.com/news/compugen-establishes-scientific-advisory-board-110000875.html Compugen Establishes Scientific Advisory Board to Guide Pipeline Program Development CBRX finance.yahoo.com/news/columbia-laboratories-regains-compliance-nasdaq-105157192.html Columbia Laboratories regains compliance with Nasdaq AMRN finance.yahoo.com/news/amarin-announces-submission-supplemental-drug-100000454.html Amarin Announces Submission of Supplemental New Drug Application for Novasep as Fourth Vascepa(R) Active Pharmaceutical Ingredient Supplier RGDX finance.yahoo.com/news/response-genetics-inc-acquires-proprietary-110000939.html Response Genetics, Inc. Acquires Proprietary FDA-Cleared and Medicare-Reimbursed Test and All Associated Assets for Difficult to Diagnose Solid Tumors ADHD finance.yahoo.com/news/alcobra-enrolls-first-patient-comparative-090000595.html Alcobra Enrolls First Patient in Comparative Study of Executive Function Benefits in Patients With PI-ADHD